Gi Distress Liquid
NDC Package 43742-1304-1
Package Information
Gi Distress (echinacea (angustifolia), natrum phosphoricum, colchicum autumnale, arsenicum album, colocynthis, croton tiglium, gambogia, aceticum acidum, antimonium crudum, bismuthum subnitricum, cinchona officinalis, ferrum metallicum, iris versicolor, lac defloratum, mercurius vivus, nux vomica, ricinus communis, veratrum album, colibacillinum cum natrum muriaticum, proteus (mirabilis)) liquids is for the temporary relief of symptoms related to occasional watery diarrhea, irritation of stomach, indigestion, abdominal bloating, stomach cramps, and loss of appetite.****These statements are based upon traditional homeopathic principles. This formulation utilizes a liquid delivery system. Marketed by Deseret Biologicals, Inc., this product is identified by NDC 43742-1304.
Identification & Billing
Clinical Specifications
- ECHINACEA ANGUSTIFOLIA WHOLE 12 [hp_X]/mL
- SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE 12 [hp_X]/mL
- COLCHICUM AUTUMNALE BULB 8 [hp_X]/mL
- ARSENIC TRIOXIDE 12 [hp_X]/mL
- CITRULLUS COLOCYNTHIS FRUIT PULP 12 [hp_X]/mL
- CROTON TIGLIUM SEED 9 [hp_X]/mL
- GAMBOGE 8 [hp_X]/mL
- ACETIC ACID 9 [hp_X]/mL
- ANTIMONY TRISULFIDE 3 [hp_X]/mL
- BISMUTH SUBNITRATE 16 [hp_X]/mL
- CINCHONA OFFICINALIS BARK 9 [hp_X]/mL
- IRON 12 [hp_X]/mL
- IRIS VERSICOLOR ROOT 12 [hp_X]/mL
- SKIM MILK 12 [hp_X]/mL
- MERCURY 16 [hp_X]/mL
- STRYCHNOS NUX-VOMICA SEED 12 [hp_X]/mL
- RICINUS COMMUNIS SEED 12 [hp_X]/mL
- VERATRUM ALBUM ROOT 6 [hp_X]/mL
- ESCHERICHIA COLI 12 [hp_X]/mL
- PROTEUS MIRABILIS 12 [hp_X]/mL
- Allergens - [CS]
- Bismuth - [CS]
- Bismuth - [EPC] (Established Pharmacologic Class)
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
- Seed Storage Proteins - [CS]
Regulatory & Marketing
Hierarchy Structure
- 43742 - Deseret Biologicals, Inc.
- 43742-1304 - Gi Distress
- 43742-1304-1 - 30 mL in 1 BOTTLE, DROPPER
- 43742-1304 - Gi Distress
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 43742-1304-1 identifies a specific commercial package of 30 ml in 1 bottle, dropper of Gi Distress, a human over the counter drug labeled by Deseret Biologicals, Inc.. This liquid is formulated for oral use and contains echinacea angustifolia whole; sodium phosphate, dibasic, heptahydrate; colchicum autumnale bulb; arsenic trioxide; citrullus colocynthis fruit pulp; croton tiglium seed; gamboge; acetic acid; antimony trisulfide; bismuth subnitrate; cinchona officinalis bark; iron; iris versicolor root; skim milk; mercury; strychnos nux-vomica seed; ricinus communis seed; veratrum album root; escherichia coli; proteus mirabilis as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Deseret Biologicals, Inc. on September 26, 2018.
How is this Deseret Biologicals, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 43742130401. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.